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Abstract  26 
Vero cell lines are extensively employed in viral vaccine manufacturing. Similarly to all established 27 
cells, mutations can occur during Vero cells in vitro amplification which can result in adverse 28 
features compromising their biological safety.  29 
To evaluate the potential neoplastic evolution of these cells, in vitro transformation test, gene 30 
expression analysis and karyotyping were compared among low- (127 and 139 passages) and high- 31 
passage (passage 194) cell lines, as well as Transformed Colonies (TCs). In vivo tumorigenicity was 32 
also tested to confirm preliminary in vitro data obtained for low passage lines and TCs. Moreover, 33 
Vero cells cultivated in foetal bovine serum-free medium and derived from TCs were analysed to 34 
investigate the influence of cultivation methods on tumorigenic evolution.  35 
Low-passage Vero developed TCs in soft agar, without showing any tumorigenic evolution when 36 
inoculated in the animal model. Karyotyping showed a hypo-diploid modal chromosome number 37 
and rearrangements with no difference among Vero cell line passages and TCs. These abnormalities 38 
were reported also in serum-free cultivated Vero. Gene expression revealed that high-passage Vero 39 
cells had several under-expressed and a few over-expressed genes compared to low-passage ones. 40 
Gene ontology revealed no significant enrichment of pathways related to oncogenic risk. 41 
These findings suggest that in vitro high passage, and not culture conditions, induces Vero 42 
transformation correlated to karyotype and gene expression alterations. These data, together with 43 
previous investigations reporting tumour induction in high-passage Vero cells, suggest the use of 44 
low-passage Vero cells or cell lines other than Vero to increase the safety of vaccine manufacturing. 45 
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Introduction 49 
A wide variety of cell cultures are used as the substrate for the production of relevant biologicals 50 
such as viral vaccines with human and veterinary applications. Cell substrates for this specific aim 51 
can be primary, diploid, stem or continuous cell lines, derived from physiologically normal, 52 
abnormal or malignant tissues (Aubrit et al. 2015). Normal tissue-derived cells can anyway undergo 53 
several modifications during in vitro cultivation, resulting in the appearance of novel biochemical, 54 
biological and genetic characteristics that differ from primary or diploid cells. In particular, these 55 
cells could acquire genetic instability as well as tumorigenic properties with increasing passages 56 
(Sheets 2000; Aubrit et al. 2015). The WHO Expert Committee reported tumorigenicity of a cell 57 
line as the ability to induce tumour formation after injection in immunocompromised animals 58 
(WHO Technical report Series, No 978, 2013, Annex 3). In fact, the utilization of tumorigenic cell 59 
lines might be involved in the transmission of tumour allographs, transforming proteins or 60 
oncogenic agents inducing tumour initiation in the recipient (Aubrit et al. 2015). 61 
In this respect, it is mandatory for vaccine production and safety assessment a fine characterization 62 
of the cell substrate in each phase of its manipulation. European Pharmacopeia recommends a panel 63 
of tests to assess cell substrate safety (Cell substrates for the production of vaccines for human use. 64 
European Pharmacopoeia Ed. 08 Chapter 5.2.3), as the use of tumorigenic cell lines for vaccine 65 
production is forbidden. Among these, to avoid potential risks related to cell transformation and 66 
tumorigenicity, both in vitro and in vivo tests are required to evaluate cell growth characteristics and 67 
reveal the onset of tumorigenic properties. 68 
Vero is a well-known immortalized cell line, used as substrate for virus isolation and production of 69 
vaccines, i.e. Poliovirus, rabies virus (Montagnon 1989), influenza (Govorkova et al. 1996; Barrett 70 
et al. 2011, 2013), and Japanese encephalitis virus (Shuller et al. 2011), due to its susceptibility to a 71 
wide range of viruses (Rhim et al. 1969; Teferedegne et al. 2014). Vero cells were originally 72 
collected from the kidney of a normal adult African Green Monkey (Cercopithecus aethiops) 73 
kidney (AGMK; Yasumura and Kawakita 1963) and immortalized through a spontaneous, unknown 74 
process (Swanson et al. 1988; Manohar et al. 2008). On the basis of CBER (Centre for Biologics 75 
Evaluation and Research) classification, Vero cells are included in neoplastic substrate category 3, 76 
in which spontaneously immortalized non-human primate cells are grouped (US FDA 2001). 77 
Previous studies demonstrated that low-passage (p140) Vero cells are not able to form tumours in 78 
vivo, neither show the formation of extraneous agent in the host, while progressively growing 79 
nodules and lung and lymph node metastases were observed at higher passages (> p200; Manohar et 80 
al. 2008). Levenbook and colleagues demonstrated nodule formation in the totality of mice 81 
inoculated with Vero cells at passages higher than 232 (Levenbook et al. 1984), while no tumour 82 
formation was observed in nude mice inoculated with p156 Vero cells by Swanson et al. (1988). On 83 
the other hand, in vitro assay gave rise to not completely clear results, since Vero cells from p127 to 84 
p140 and from p162 to p265 formed colonies in soft agar (Petricciani et al. 1987).  85 
These findings, taken together, indicated Vero cells as a suitable and safe biological resource for 86 
vaccine production only at low passages, but data are still controversial due to the lack of 87 
consistence between in vitro and in vivo tests. Moreover, the mechanism inducing neoplastic 88 
transformation in Vero cells remains an elusive point (Manohar et al. 2008). 89 
The application of serum-free media has become established recently to cultivate cells without the 90 
addition of animal derivatives. Despite the positive aspects of serum addition to media (related to 91 
cell attachment and growth), the employment of serum in cell cultures has some disadvantages 92 
(Chen and Chen 2009), such as the uncertainty of the composition and the putative contamination 93 
with adventitious agents. Previous studies demonstrated the ability of Vero cells to grow in animal 94 
serum-free medium while maintaining their permissiveness to viral propagation (Frazatti-Gallina et 95 
al. 2004; Chen et al. 2011), suggesting the applicability of serum-free medium in vaccine 96 
manufacturing. To date no data is available on the correlation between culture conditions and 97 
neoplastic phenotype evolution in Vero cells. 98 
The present study aimed to characterize in vitro amplified Vero cells at low and high passages. 99 
Additionally, normal and serum-free growth conditions were tested. Transformation ability of low 100 
and high-passage cells was investigated by soft agar transformation assay. Moreover, p127 and 101 
p139 Vero cells were tested for tumorigenic phenotype by nude mice inoculation. With the aim of 102 
shedding light on the mechanisms inducing the neoplastic phenotype, cell lines were analysed 103 
through karyotyping and gene expression study. To study the behaviour of the in vitro transforming 104 
samples, six of the soft agar transforming colonies were amplified, evaluated by inoculation in soft 105 
agar and in nude mice and examined by karyotyping. 106 
Material and methods 107 
Cell culture 108 
Vero cells (African green monkey kidney, IZSLER Cell Bank code BS CL 86) were received from 109 
ATCC (American Type Culture Collection) at p124 and grown in MEM culture medium (Eagle’s 110 
Minimum Essential Medium in Earle’s BSS) enriched with 10% Fetal Bovine Serum (FBS) and 2 111 
mM L-glutamine. From p127 they were grown concurrently in serum-free medium. XerumFree™ 112 
XF205 Medium Supplement (TNC BIO, Eindhoven, Holland) was gradually added to cultural 113 
medium in substitution of FBS, starting from 50% XerumFree-supplemented medium/50% FBS-114 
supplemented medium, according to manufacturer instructions. Cultures adapted to serum-free 115 
conditions were amplified in medium supplemented with Epidermal Growth Factor (EGF; 12.5 116 
µg/L, Sigma Aldrich, Milano, Italy) and insulin (1.25 mg/L, Sigma Aldrich). At each passage, cells 117 
were mechanically scraped and incubated in a mixture of 75% fresh medium and 25% conditioned 118 
medium, collected during the previous passage. 119 
HEp-2 (Human larynx epidermal carcinoma, BSTCL 23) and MRC-5 cells (Human foetal lung, 120 
BSCL 68), were grown in MEM culture medium supplemented with 10% FBS and 2 mM L-121 
glutamine. These cell lines were used respectively as positive and negative control in tumorigenicity 122 
and transformation assays. 123 
A primary cell culture (passage 3) of a normal adult African Green Monkey Kidney (AGMK, 124 
Cercopithecus aethiops) was kindly provided by Dr. Brandini (Novartis Vaccines Italia, Siena, 125 
Italy) and grown in MEM culture medium enriched with 10% FBS, 1% Penicillin/Streptomycin and 126 
2 mM L-glutamine. This cell line was used as reference in the in vitro transformation assay and 127 
karyotype analyses.  Figure S1 summarizes cell lines used in each investigation reported hereunder. 128 
In vitro transformation assay 129 
Vero (from p127 to p139 and p194), as well as AGMK, MRC-5 and Hep2 negative and positive 130 
control cells were assayed for in vitro transformation according to European Pharmacopoeia 131 
guidelines, by seeding cell lines in semi-solid agar medium (Macpherson and Montagnier 1964). 132 
Briefly, 1% agar noble was mixed with 50% of 2X MEM, supplemented with 20% FBS and 133 
stratified into 6-well plates (3 ml/well). 105 p139 Vero cells were diluted in 1 mL of 20% FBS-134 
MEM (v/v) and 0.6% noble agar and gently layered onto solidified agar. Plates were incubated at 135 
37°C in 5% CO2 for 3 weeks and inspected daily to detect TCs. To assess serum free-culturing 136 
conditions, the same cells were grown in medium supplemented with Xerum-free instead of FBS 137 
before in vitro transformation assay. 138 
Isolation and amplification of Vero transformed colonies (TCs) 139 
Six TCs developed in the soft agar assay, originated from p139 Vero, were collected under sterile 140 
conditions and disaggregated mechanically. Cells derived from each single colony were inoculated 141 
in a well of a 48-well plate and grown in the previously described medium. When cells reached 142 
80%-confluence, they were serially amplified and characterized as described below. 143 
In vivo tumorigenicity test 144 
The choice of the animal model for in vivo tests was based on the results of published investigations 145 
reporting the validity of experimental data produced on adult nude mice (Swanson et al., 1988; 146 
Zhang et al., 2004; Manohar et al. 2008) and on European Pharmacopoeia guidelines.  147 
Vero cell samples (at p127 and p139, serum-added and serum-free cultured), as well as the six TC 148 
samples and positive (Hep-2) and negative (MRC-5 and AGMK) controls were inoculated into nude 149 
mice to verify tumorigenic potential in vivo. According to Directive 2010/63/EU and the 3Rs 150 
principle stated by Russell and Burch (1959), the high passage (p194) Vero cells were not included 151 
in the in vivo test, as they were previously demonstrated to induce tumour formation in nude mice 152 
(Petricciani et al. 1987). 153 
In vivo tests were performed as described in European Pharmacopoeia guidelines in 20-day-old 154 
male athymic mice (Nu/Nu genotype), received from Harlan Laboratories (Milan, Italy) in 155 
accordance with local animal welfare guidelines. Ten mice per treatment (Vero p127, Vero p139, 156 
the six TCs and positive and negative controls) were used. They were sub-divided into groups of 157 
five mice/cage, maintained at the IZSLER Division of Laboratory Animal on sterile bedding and 158 
given water and feed ad libitum. Animals were injected subcutaneously into the abdominal wall 159 
with a 107-cell suspension in 0.2 mL of volume. Five mice were sacrificed by CO2 inhalation three 160 
weeks after the treatment, while the others were inspected daily for 12 weeks. The regional lymph 161 
nodes, lung, brain, spleen, kidney, liver and the injection site were examined post-mortem to detect 162 
tumours, for histological examination and haematoxylin-eosin staining. 163 
Cell karyotype evaluation 164 
Cytogenetic studies were performed on chromosomes derived from AGMK (control cell line) and 165 
Vero cells collected at different passages (from p127 to p139 and p194), cultured both with FBS 166 
and Xerum-free supplement. Cell lines derived from the six Vero-transformed colonies (TCs) were 167 
also analysed.  168 
Chromosome preparations were obtained according to standard cytogenetic techniques. Cytogenetic 169 
analysis was performed using Quinacrine staining (0.05 mg/mL Quinacrine Mustard 170 
Dihydrochloride C23H28Cl3N3O 2HCl, Sigma-Aldrich, Milan, Italy) and analysing an average of 171 
twenty metaphases per sample. Karyotypes were compared with the normal primate karyotype 172 
(Finaz et al. 1976). 173 
Gene expression analysis 174 
Differences in gene expression were investigated comparing low (p127, p134) and high (p194) 175 
culture passages of Vero cells cultured in the presence of FBS. Total RNA was extracted from 107 176 
cells using RNeasy Mini Kit with a QIAcube platform (Qiagen, Milan, Italy) according to the 177 
instructions of the manufacturer. RNA quantity and quality were assessed by a 2200 TapeStation 178 
RNA Screen Tape device (Agilent, Santa Clara, CA, USA) and a ND-1000 spectrophotometer 179 
(NanoDrop, Thermo Scientific, Wilmington, DE), respectively. 180 
Libraries were prepared with the TruseqRNA sample prep kit (Illumina, Inc. San Diego, CA) 181 
following manufacturer’s protocol and their evaluation was made with a Tape Station 2200. 182 
Indexed libraries were quantified by Picogreen (Life Technologies, Monza, Italy) and then 183 
normalized to 10 nM for cluster generation on a Hiseq2000 (Illumina). Equimolar amounts of each 184 
library were mixed before NaOH denaturation and pooled samples were run in a total of two lanes 185 
of a Hiseq Flowcell (Illumina).  186 
The Truseq PE cluster kit v3 was used to generate clusters on the grafted Flowcell and the 187 
hybridized libraries were sequenced on a Hiseq2000 with a 100 cycles of paired-end sequencing 188 
module using the Truseq SBS kit v3. 189 
RNA-seq data analysis 190 
Standard trimming was performed using Trimmomatic software, to remove the adapters and check 191 
the quality of the reads (Bolger et al. 2014). Only RNA-seq reads that passed the trimming 192 
procedures were mapped to "Vervet Monkey" reference genome (Green monkey chlSab1, Jun 2013, 193 
Chlorocebus_sabeus 1.0/chlSab1, Vervet Genomics Consortium GCA_000409795.1) using Star 194 
aligner, with default parameters (Dobin et al. 2013). Alignments were sorted using Samtools 195 
software (Li et al. 2009). For each sample, the number of reads mapped into each specific gene was 196 
calculated using htseq-count program (Anders et al. 2015). 197 
Differential expression among pairwise comparisons was analysed using the edgeR package 198 
(Robinson et al. 2010). EdgeR permits to estimate a common dispersion to the theses to be 199 
compared even in the absence of biological replicates (Bioconductor). Hence, edgeR permits the 200 
statistical analysis of data lacking replicates and conduct exact tests of significance for the negative 201 
binomial distribution in pairwise comparisons. 202 
A multiple testing correction was applied to determine the false discovery rate (FDR; Reiner et al. 203 
2003). Genes with a FDR-adjusted p-value (q-value) of  0.05 and log fold change lower than -3 204 
and higher than 3 were considered to be Differential Expressed Genes (DEGs). Groups of genes 205 
significant in a single or in multiple comparisons have been graphically represented by Venn 206 
analysis.  207 
Ontology and clustering of differentially expressed genes 208 
Clustering of gene expression levels in each sample and differential gene expression in pairwise 209 
comparisons were also produced for DEGs identified by contrasting p127, p134 and p194 Vero 210 
cells and visualized as heatmaps and dendrograms. Dendrograms were generated with Euclidian 211 
distance as measure of dissimilarities and complete linkage as agglomeration method using dist and 212 
hclust function implemented in R packages. Gene Ontology (GO) analysis was carried out using 213 
g:Profiler, a web server for functional interpretation of gene list (Reimand et al. 2016). 214 
Results 215 
In vitro transformation assay 216 
Foci formation took place for HEp-2 cells, used as positive control (Fig. 1B), and all Vero cell lines. 217 
Foci appeared 7 days after the inoculum and gradually increased in both number and size. An 218 
example is reported in figure 1A, reporting cells at passage 130. TCs isolated from p139 Vero cells 219 
and assayed for in vitro transformation also produced foci of transformed colonies. 220 
No significant difference was observed among samples at different passages and culture conditions. 221 
Results are summarized in Table 1 and Figure S1. 222 
Conversely, no transformed colony was observed in the negative control MRC-5 and AGMK 223 
cultures, where cells remained unaltered during all the observation period (Fig. 1C). 224 
In vivo tumorigenic test 225 
Both inoculation of MRC-5 cells (negative control) and Vero cells (at passage p127, p136 and TCs 226 
in both culture conditions) did not induce tumour formation during the observation period. Results 227 
of the in vivo tumorigenicity are summarized in Table 1 and Figure S1. No macroscopic lesion and 228 
inflammatory process were observed in treated animals and the inoculum was re-absorbed 229 
completely within few days (an average of seven days). The necropsy detected no tumour formation 230 
at the site of inoculation neither in other organs and tissues, with no macroscopic lesions. These 231 
observations were confirmed by histological examination. Mice showed hyperkeratosis, moderate 232 
lymphoplasmacellular enteritis and dismicrobism bowel, pulmonary bleeding and rare intracranial 233 
bleeding, but neither microscopic anomalies nor neoplastic cells were observed in all tissues 234 
examined. 235 
In contrast, tumours were detected in all mice receiving HEp-2 cells. In particular, nodules were 236 
observed at the inoculation site about 10 days after the injection. They appeared smooth, uniform 237 
and globular (10 mm Ø); later they developed a multi-globular shape and increased in size (20 mm 238 
Ø). At about 30 days after the injection, the mice were sacrificed to avoid animal pain and suffering. 239 
At necropsy, no other macroscopic alterations in organs and tissues were detected. The histological 240 
examination of the mice injected with HEp-2 cells showed the presence of polygonal cells in 241 
subcutaneous and dermal tissues; the nuclei of such cells were irregular in shape, with evident 242 
nucleoli (atypical mitosis); moreover, neoplastic cells were observed in the vessels. These 243 
alterations were restricted to the inoculum site in all the animals and no metastases were found. 244 
Cell karyotype evaluation 245 
AGMK cell line karyotype showed normal diploid number of chromosomes (2n = 60; Finelli et al. 246 
1999). All analysed Vero samples at different passages showed hypodiploid chromosome count. 247 
The modal chromosome number was 56 with a range from 54 to 58 (as reported in the ATCC site) 248 
occurring in 75% of cells. In most cells, over 50% of the chromosomes in each metaphase were 249 
structurally altered marker chromosomes. The rate of cells with higher ploidies was 2%, while 250 
different chromosomes were present in single copy in different cell cultures. The chromosomal 251 
asset of Vero cell lines resulted stable without significant differences between the assayed in vitro 252 
passages (Figure 2). The chromosome analysis of TC colonies, originated from p139, and of serum-253 
free cultivated Vero cells, showed the same abnormal karyotype. Results of karyotyping are 254 
summarized in Table 1.  255 
Gene expression analysis  256 
Gene expression data revealed that some of the 20.126 unique genes identified, were expressed only 257 
in one of the passages analysed. Specifically, a total of 89 (4.42%), 175 (8.70%) and 220 (10.93%) 258 
genes were found exclusively expressed in p127, p134 and p194 respectively, and not elsewhere. 259 
Comparing the three Vero passages, 350 genes were found differentially expressed in one or more 260 
pairwise comparisons. Among these, 41 were DEGs between p127 and p134 Vero cells, and 309 261 
between these two lines and p194 Vero. No gene was differentially expressed in all comparisons 262 
(Fig. 3). 263 
The logarithm of the normalized expression level of the 309 genes differentially expressed 264 
comparing the high passage (p194 Vero) to low passages (p127 Vero and p134 Vero) are shown in 265 
Figure 4. DEG analysis indicated that p127 Vero and p134 Vero have very similar gene expression 266 
(lane 1). Additionally, the comparison between p127, p134 and p194 Vero cells (lane 2 and 3) 267 
indicates that p194 Vero cells have a larger number of down-regulated genes compared to up-268 
regulated ones as 231 and 228 genes out of 309 were under-expressed in p194 Vero compared to 269 
p134 and p127 cells, respectively.  270 
Table S1 reports values of log Fold-change of expression in pairwise comparisons.  271 
Function of differentially expressed genes 272 
The main biological processes identified by GO analysis were relative to response to corticotropin-273 
releasing hormone, response to growth factor and sprouting angiogenesis. GO analysis showed no 274 
significant enrichment of DEG in metabolic pathways relative to oncogenesis.  275 
Discussion 276 
Vero cells are commonly used in human and veterinary vaccine production and their safety has 277 
been widely investigated. A particular concern is related to the tumorigenicity of this cellular 278 
substrate, since a potential tumorigenic evolution of in vitro-maintained Vero cells (passages from 279 
131 to 227) has been reported by many authors (Van Steenis and van Wezel 1981; Contreras et al. 280 
1985; Furesz et al. 1989; Zhang et al. 2001). Indeed, data are still controversial because other 281 
studies showed that these cells did not acquire tumorigenic features at passages higher than 140 282 
(Johnson et al. 1981; Levenbook et al. 1984; Swanson et al. 1988). 283 
As mentioned above, transforming phenotype (defined as the ability of cells to proliferate without 284 
undergo the common proliferative controls; Hoff et al. 2004) and tumorigenicity (the ability of 285 
cultured cells to originate progressively growing tumours) can be respectively evaluated in vitro 286 
(soft agar assay) and in vivo (inoculation in nude mouse).  287 
Among in vitro tests, the soft-agar assay is widely applied, as it is an easy and low-cost test 288 
recommended by the European Pharmacopoeia to assess cellular substrates safety. Regarding the in 289 
vivo test, two different animal models are used: rat and mouse. In particular, Van Steenis and van 290 
Wezel (1981) showed that anti-thymocyte globulin (ATG)-treated new-born rats developed tumours 291 
at the inoculation site and metastases, demonstrating that they were more sensitive than nude mice. 292 
In addition, the results of another study on athymic nude mice, suggested a possible correlation 293 
between the chromosome abnormalities of cell lines and their tumorigenic ability (Zhang et al. 294 
2004). 295 
Concerning our research, different methodologies were used to assess the tumorigenic potential of 296 
Vero cell lines at different passages, cultivated on different media and of TCs, with the aim of 297 
investigating the safety of this biological substrate commonly applied in vaccine manufacture. 298 
Moreover, after the assessment of the tumorigenic phenotype, karyotyping and RNASeq 299 
experiments were carried out to search for biological alterations correlated to transformation. 300 
Low- (from p127 to p139), high- (p194) passage Vero cells, as well as TCs, maintained in serum-301 
supplemented and serum-free medium, were able to develop transformed colonies in the soft agar 302 
semi-solid medium with consistent timings and amounts, suggesting a common transformed genetic 303 
pattern. This result confirmed previous observation at the Cell Culture Centre of TC development in 304 
Vero cell cultures starting from different batches and passages. 305 
In nude mice inoculated with p127 and p139 passages of Vero cells cultured with and without 306 
serum, no tumour was detected at the site of injection and cells were absorbed rapidly. These results 307 
are consistent with other studies that confirmed the absence of tumour formation at low Vero 308 
passages (Levenbook et al. 1984; Manohar et al. 2008). 309 
The absence of correlation between in vitro and in vivo results contrasts what found in a previous 310 
study, in which different passage of cells (p146-p227, Furesz et al. 1989) were positive to both tests. 311 
One possible reason of this inconsistency could be the limited time length of the investigation, 312 
lasted 84 days (12 weeks). However, this period is beyond the limit of 69 days suggested by 313 
Manohar et al. as a lower limit by which tumour formation can be observed in adult nude mice 314 
(2008). Additionally, Furesz et al. reported tumour formation only after 21 days of observation 315 
(1987). These results suggest that the tumorigenic phenotype evolution is not correlated only to 316 
passage numbers, but to the target of genetic modification Vero cells have undergone during 317 
culturing.  318 
Tumour-forming ability in nude mice may be associated to chromosome number variation. All 319 
samples of Vero cells showed a modal chromosome number (56, range 54-58) lower than the 320 
normal chromosome number of the AGMK (2n = 60; Finelli et al. 1999). No other chromosomal 321 
abnormality was detected by cytogenetic analyses in the cells amplified serially, which were devoid 322 
of any malignant appearance. 323 
Gene expression is influenced by cell immortalization and in-vitro culture (Ma et al. 2012; 324 
Dequéant et al. 2015; Garcia-Mesa et al. 2016). In particular, the number of in-vitro passages seems 325 
to influence gene regulation. Specifically, close passages induced differences in the expression of 326 
few genes (41 between p127 Vero and p134 Vero), while 4 to 6 fold increase in the number of 327 
differentially expressed gene are shown comparing p194 Vero with either p127 Vero or p134 Vero. 328 
If this pattern is common to long-term culture of all cell lines or specific to the Vero cells is to be 329 
investigated. Also it is presently unknown if gene expression gradually changes during passages or 330 
if a threshold exists beyond which cells start to change gene regulation. 331 
However, the analysis of gene ontology and function of differentially expressed genes did not 332 
reveal changes that justify the tumorigenicity of p194 Vero cells observed in other investigations 333 
(Petricciani et al. 1987). Interestingly, Vero p194 showed a rather large cluster of downregulated 334 
genes and only few upregulated ones, when compared to the earlier passages; in addition GO of 335 
DEGs revealed no evidence of significant enrichment in cancer pathways. 336 
In summary, we found no significant difference among low (p127 and p134) and high (p194) Vero 337 
passages in terms of transformation ability and karyotype. Differences in gene expression were 338 
detected, but metabolic pathways affected do not appear to be correlated to tumorigenesis. The 339 
choice of not testing in vivo p194 was undoubtedly a limitation, as the tumorigenicity of this 340 
passage at Cell Culture Center was inferred on the basis of external references. Joining our with 341 
existing results suggests that Vero are potentially tumorigenic cells, able to form TC even at low 342 
passages. The switch between these two states depends on random events and mechanisms that so 343 
far have not been identified but whose probability increases with the number of passages.  344 
Therefore the use of Vero cells for biological production (such as Poliovirus vaccine manufacture) 345 
is suggested at the lowest possible available passage (Aubrit et al. 2015) to minimise risk. Such 346 
limitation strongly suggests to move towards already available alternative cell lines, such as FRhK-347 
4 and 4647 lines in Poliovirus vaccine production (Dotti et al. 2017), as well as the so-called 348 
“designer” cell lines, as proposed by Brown and Mehtali (2010).  349 
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Figure legend 461 
Fig. 1 In vitro transformation assay 462 
Transformed colonies produced in soft-agar by Vero (p130) and HEp-2 cell lines (positive control) 463 
are shown respectively in figure 1A e 1B, while results from AGMK (one of the two negative 464 
controls) are reported in figure 1C. 465 
Fig. 2 Metaphase of p127 Vero 466 
The arrows shows two of the rearranged chromosomes.  467 
Fig. 3 Differential expressed genes in pairwise comparisons among the three Vero lines tested. 468 
Venn diagrams report graphically the number of DEGs in single and multiple comparisons of the 469 
indicated Vero passages. Intersections define groups of DEGs resulted common to two or more 470 
comparisons. 471 
Fig. 4 Heat map reporting log fold change of the DEGs identified in p127 Vero- p134 Vero and 472 
p134 Vero-p194 Vero comparisons  473 
Log fold-changes are depicted with a colour scale where red represents the up-regulated genes and 474 
green represents the down-regulated ones. Up- and down-regulation is referred to the first term of 475 
the comparison reported in the label at the bottom of the figure. Rows and columns are sorted on the 476 
basis of cluster analysis of gene expression similarities. The heat map was generated in R. 477 
Fig. S1: Graphical representation of the experimental design and major results of the study. Dots in 478 
the in vitro section means positivity to the test. The red circle in the in vivo experiment means 479 
tumour formation after inoculum of the cell line in nude mice. 480 
Table legend 481 
Tab. 1: Summary of the main results of the study.  482 
Tab. S1: Log fold-change of DEGs in pairwise comparisons. the first column reports feature IDs 483 
obtained in the RNA-seq experiment. Columns 2, 3 and 4 show log fold-change values of each 484 
pairwise comparison. A positive value means higher expression in the first term of the comparison; 485 
on the contrary, a negative value means higher expression in the second term of the comparison. 486 
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In vitro 
transformationa 
In vivo 
tumorigenicity 
Karyotypinga,b RNA-seq 
p127 Vero + - 56 No enrichment in 
genes involved in 
tumorigenesis 
p134 Vero + - 56 
p194 Vero + +* 56 
TCs + - 56 NP 
p3 AGMK - - 60 NP 
Hep-2 + + NP NP 
MRC-5 - - NP NP 
a in vitro transformation and karyotyping were performed on cells from p127 to p139. For sake of simplicity, 
Table 1 reports only data of lines that undergo also other steps of the investigation.  
* result based on Petricciani et al. 1987. 
b table reports the observed modal chromosome number based on the observation of 20 metastases. 
NP = not performed. 
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JK123643.1_1 -1,062622151 2,840022258 3,904691719 
ENSP00000339820_1 1,457722446 -2,533940122 -3,99387525 
ENSP00000422591_1 1,155605447 -2,483506176 -3,640560211 
ENSP00000343877_1 0,800559522 -2,307131495 -3,108510429 
ENSP00000251127_1 2,125696429 -2,312850716 -4,443108734 
ENSP00000238682_1 -0,601238224 2,486957226 3,089182109 
ENSP00000353582_1 2,856619736 -0,194009849 -3,051789143 
ENSP00000310721_1 1,060947919 -2,531315827 -3,594915025 
ENSP00000451438_1 1,444405038 -2,26859334 -3,717191588 
ENSP00000256759_1 2,356003056 -1,86481169 -4,229721337 
ENSP00000256925_1 0,716978005 -2,616474902 -3,336976958 
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ENSP00000375847_1 -0,940343322 2,081489799 3,033783535 
JK114877.1_1 -1,058101239 1,930739851 3,000714117 
ENSP00000279168_1 -2,109080656 1,08642636 3,210073333 
ENSP00000265165_1 1,643620071 -1,385852613 -3,041056528 
ENSP00000265131_1 2,463387293 -0,764130648 -3,241878669 
JK122975.1_1 -0,917834535 2,240778191 3,173665605 
ENSP00000353198_1 -0,802890875 2,636214623 3,459475153 
ENSP00000340943_1 2,014504239 -2,589510109 -4,660583434 
ENSP00000270172_1 -1,071545656 3,494563012 4,625303798 
ENSP00000365105_1 -1,472182758 2,344745534 3,847272646 
ENSP00000303208_1 -1,997112147 1,08642636 3,097972175 
ENSP00000349022_1 -2,281802391 1,076089138 3,37731403 
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ENSP00000299882_1 -1,251684267 5,693342571 7,431683718 
ENSP00000317027_1 1,733668776 -1,372189202 -3,120305859 
ENSP00000252723_1 -2,102208591 1,622630781 3,754546883 
ENSP00000357301_1 -0,541242796 3,182756266 3,754546883 
ENSP00000368477_1 -0,389345802 6,488698754 7,364967387 
ENSP00000331065_1 -0,858796027 3,494563012 4,412194339 
ENSP00000387278_1 -0,319548745 6,488698754 7,295015584 
ENSP00000458307_1 -3,036675243 3,774650585 7,295015584 
JK105864.1_1 -0,798781575 6,009683671 7,295015584 
ENSP00000353142_1 -1,696123147 1,481862791 3,197464018 
ENSP00000375259_1 -1,545043532 2,028404435 3,603225567 
JK125686.1_1 -1,071545656 2,057501577 3,148766038 
ENSP00000253354_1 0 -6,730042384 -7,216713304 
ENSP00000368102_1 5,336805398 -1,442473467 -7,216713304 
ENSP00000257860_1 -2,886053168 3,774650585 7,144032866 
ENSP00000444948_1 -2,886053168 3,774650585 7,144032866 
ENSP00000268459_1 -1,280651129 1,798203891 3,098366666 
ENSP00000412130_1 -2,158417484 1,946539195 4,162056544 
ENSP00000439182_1 -1,721408072 1,622630781 3,373084953 
ENSP00000339767_1 -0,479958914 6,009683671 6,975382319 
ENSP00000370770_1 -6,539379833 0 6,975382319 
ENSP00000417710_1 -1,769797766 4,72095754 6,975382319 
ENSP00000312457_1 2,348618007 -0,711464499 -3,078735886 
JK125441.1_1 2,014504239 -2,086371899 -4,156349512 
ENSP00000306275_1 0 -6,469723486 -6,955617397 
JK116968.1_1 3,82152725 -2,695072901 -6,955617397 
ENSP00000350976_1 -6,44730409 0 6,883037048 
ENSP00000297161_1 1,125520326 -2,229534483 -3,384234719 
ENSP00000205890_1 -0,868578633 2,344745534 3,242601648 
ENSP00000261275_1 2,014504239 -2,009084844 -4,078857564 
JK107001.1_1 -1,937998351 1,946539195 3,941122022 
JK118361.1_1 -1,37077502 2,513150573 3,941122022 
ENSP00000274532_1 3,82152725 -2,596699454 -6,856911712 
ENSP00000445247_1 -2,527421587 3,774650585 6,784374174 
JK110883.1_1 -1,57936677 4,72095754 6,784374174 
JK124819.1_1 -0,128844757 3,014396168 3,172649845 
JK113872.1_1 -6,625930005 -2,774418344 3,859259746 
ENSP00000289388_1 -2,421867208 3,774650585 6,678465391 
ENSP00000379684_1 0,485963278 6,679334305 6,678465391 
ENSP00000396755_1 -2,421867208 3,774650585 6,678465391 
JK101839.1_1 -0,90658906 5,287568917 6,678465391 
ENSP00000064724_1 -1,448050845 1,622630781 3,099132689 
ENSP00000361935_1 3,563767563 -0,292833817 -3,91014443 
ENSP00000327538_1 -0,479958914 3,235265327 3,772471476 
ENSP00000351805_1 -1,202574435 2,513150573 3,772471476 
ENSP00000364348_1 -0,000726084 3,71428041 3,772471476 
ENSP00000411145_1 0,189977903 3,90491596 3,772471476 
JK119441.1_1 -0,220534441 3,494563012 3,772471476 
ENSP00000287713_1 2,674783651 -0,461061027 -3,163228536 
ENSP00000300961_1 -1,937998351 1,056019403 3,021667127 
JK100196.1_1 -0,964689576 2,028404435 3,021667127 
JK121760.1_1 -1,937998351 1,056019403 3,021667127 
JK107401.1_1 0 -6,151859094 -6,636592175 
ENSP00000349401_1 0,599854487 6,679334305 6,564161444 
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feature IDs p134 vs p127 p194 vs p127 p194 vs p134 
JK091637.1_1 -2,307975999 3,774650585 6,564161444 
ENSP00000223364_1 -2,625776839 1,000232241 3,680126205 
JK099475.1_1 -6,44730409 -2,774418344 3,680126205 
ENSP00000278314_1 0,532809253 6,488698754 6,440015926 
ENSP00000326031_1 -2,184317246 3,774650585 6,440015926 
JK122419.1_1 -0,669039098 5,287568917 6,440015926 
ENSP00000219070_1 2,58172757 -1,083781122 -3,719055972 
ENSP00000315295_1 1,066449422 -2,596699454 -3,719055972 
ENSP00000360269_1 1,066449422 -2,596699454 -3,719055972 
ENSP00000359512_1 -1,012143439 2,513150573 3,581463331 
ENSP00000421258_1 -2,527421587 1,000232241 3,581463331 
JK097403.1_1 -1,57936677 1,946539195 3,581463331 
ENSP00000299727_1 1,066449422 -2,491124118 -3,613097854 
ENSP00000344173_1 1,066449422 -2,491124118 -3,613097854 
ENSP00000277517_1 -2,421867208 1,000232241 3,475554547 
ENSP00000300079_1 -2,421867208 1,000232241 3,475554547 
ENSP00000323155_1 -1,473812391 1,946539195 3,475554547 
ENSP00000473361_1 -2,421867208 1,000232241 3,475554547 
JK100278.1_1 -0,500503616 2,918924227 3,475554547 
ENSP00000343782_1 0 -5,892876977 -6,376454814 
ENSP00000356771_1 3,82152725 -2,118226391 -6,376454814 
JK094464.1_1 4,769582067 -1,171919437 -6,376454814 
ENSP00000158762_1 -0,533778926 5,287568917 6,304173084 
ENSP00000252085_1 -2,049057074 3,774650585 6,304173084 
ENSP00000363081_1 0,448261067 6,268981357 6,304173084 
ENSP00000365173_1 -2,049057074 3,774650585 6,304173084 
ENSP00000406318_1 0,448261067 6,268981357 6,304173084 
JK098797.1_1 -0,533778926 5,287568917 6,304173084 
ENSP00000263326_1 1,066449422 -2,377208509 -3,498736436 
ENSP00000319744_1 -0,792697851 2,513150573 3,361250601 
ENSP00000396622_1 -2,307975999 1,000232241 3,361250601 
ENSP00000439601_1 -2,307975999 1,000232241 3,361250601 
JK095107.1_1 -6,129503249 -2,774418344 3,361250601 
JK106362.1_1 -1,359921182 1,946539195 3,361250601 
JK106489.1_1 -2,307975999 1,000232241 3,361250601 
JK109650.1_1 -2,307975999 1,000232241 3,361250601 
JK113424.1_1 -0,792697851 2,513150573 3,361250601 
ENSP00000269703_1 0 -5,743569099 -6,226379856 
ENSP00000339256_1 4,769582067 -1,022611559 -6,226379856 
ENSP00000421169_1 0 -5,743569099 -6,226379856 
ENSP00000263266_1 -5,721318377 0 6,154197121 
ENSP00000288065_1 -5,721318377 0 6,154197121 
ENSP00000359904_1 -1,899791127 3,774650585 6,154197121 
ENSP00000377971_1 -0,95173631 4,72095754 6,154197121 
JK108999.1_1 -1,899791127 3,774650585 6,154197121 
ENSP00000324248_1 -0,181910154 8,599408654 8,789084031 
ENSP00000353427_1 0,71421195 5,084041388 4,370184695 
JK092522.1_1 0,367485659 5,237883461 4,872112057 
ENSP00000368759_1 0,689440424 5,368665504 4,681425579 
ENSP00000227756_1 0,552701821 3,786515271 3,234266241 
ENSP00000358590_1 1,653658391 6,0919394 4,445735231 
ENSP00000264381_1 2,130470642 11,68243599 10,04205614 
ENSP00000303153_1 0,304128115 -3,463999919 -3,768493664 
ENSP00000349677_1 0,054360726 -3,484326888 -3,539031379 
feature IDs p134 vs p127 p194 vs p127 p194 vs p134 
ENSP00000338217_1 1,191306037 7,318383043 6,149402417 
ENSP00000274364_1 0,117793789 3,652874361 3,536050196 
ENSP00000285013_1 1,625542932 11,28047863 10,14505526 
ENSP00000245479_1 1,565281705 4,818160459 3,256862291 
ENSP00000453969_1 0,457703678 3,488654187 3,031753663 
ENSP00000294829_1 -0,015677254 5,314613765 5,337880969 
ENSP00000225688_1 0,642624312 4,380592676 3,741093582 
ENSP00000344479_1 0,922045685 4,3549569 3,436136349 
ENSP00000420194_1 0,290320978 4,950615121 4,666434216 
ENSP00000463533_1 -1,122613762 -4,914719 -3,794097732 
JK100938.1_1 -0,065535489 3,336762118 3,403557144 
ENSP00000262352_1 -0,006936532 3,568509701 3,577201903 
ENSP00000363512_1 0,778781547 4,068080797 3,292656382 
ENSP00000361917_1 0,631291635 4,294327128 3,667380681 
ENSP00000365651_1 0,804908223 3,914597967 3,112835241 
ENSP00000377003_1 0,506681443 4,664149 4,164831046 
ENSP00000289547_1 0,103512235 3,160259547 3,058106196 
ENSP00000222219_1 0,17726651 7,521275207 7,40574109 
ENSP00000354794_1 -0,198641815 -3,890445652 -3,695132826 
JK111776.1_1 -0,730775564 3,872267778 4,608644528 
ENSP00000312368_1 1,020220817 9,666964492 9,136362402 
ENSP00000359778_1 2,599899753 -3,319460074 -5,935305493 
ENSP00000312070_1 1,538301839 4,732925929 3,210073333 
ENSP00000332530_1 0,516177542 3,923066384 3,414835272 
ENSP00000261180_1 -2,755077828 -9,406570964 -6,75869621 
ENSP00000321049_1 1,076214207 4,365262962 3,301560636 
ENSP00000310878_1 -1,073506427 -5,668703555 -4,611035031 
ENSP00000343617_1 0,485698558 4,274266183 3,801437579 
ENSP00000393198_1 1,254115287 4,242612166 3,000714117 
ENSP00000405218_1 0,874803004 9,025511724 8,639917969 
JK123722.1_1 -0,587833907 8,953503899 10,03133995 
ENSP00000399985_1 -0,90658906 -4,106529587 -3,205608776 
ENSP00000369129_1 0,29525929 -3,178480499 -3,47879616 
ENSP00000473091_1 0,886239757 8,575865029 8,178313786 
JK117245.1_1 1,631667636 8,575865029 7,431683718 
ENSP00000361788_1 0,799159501 4,315606014 3,537208263 
JK093232.1_1 -0,003098682 3,023228795 3,03248401 
ENSP00000296327_1 0,234409912 3,3673204 3,141759979 
ENSP00000442046_1 5,336805398 -3,636905417 -9,414212059 
ENSP00000264072_1 -1,073506427 -4,797974138 -3,739810357 
ENSP00000386393_1 0,585638827 8,313586582 8,216656867 
ENSP00000282326_1 0,316319891 8,25488182 8,427499498 
JK093866.1_1 0,104105852 8,25488182 8,639917969 
ENSP00000320604_1 1,536444446 5,41926826 3,941122022 
ENSP00000321962_1 -0,384512979 -3,491001357 -3,114019729 
JK093908.1_1 -0,048930561 5,355361883 5,46495195 
ENSP00000281821_1 0,881604714 4,984907225 4,162056544 
ENSP00000337555_1 -0,274097662 4,984907225 5,319478398 
JK095209.1_1 0,631962847 7,759325569 7,615105183 
ENSP00000216733_1 0,603380389 4,897860488 4,353607229 
ENSP00000384193_1 1,47914882 4,897860488 3,475554547 
ENSP00000379353_1 -0,533888103 4,007340696 4,572910861 
ENSP00000272252_1 0,190875185 4,805222523 4,674001778 
ENSP00000349678_1 1,003959169 4,805222523 3,859259746 
feature IDs p134 vs p127 p194 vs p127 p194 vs p134 
ENSP00000279441_1 -0,334001583 3,547845789 3,902901476 
JK099477.1_1 0,411710778 4,70622545 4,353607229 
JK099942.1_1 0,904943663 4,70622545 3,859259746 
ENSP00000290552_1 0,746017424 3,815705657 3,099132689 
ENSP00000344674_1 -1,014081553 3,460799052 4,496372873 
ENSP00000472867_1 -0,093062449 3,460799052 3,574558612 
ENSP00000310880_1 -0,752437392 7,480643794 8,722179193 
ENSP00000346990_1 0,353232249 7,480643794 7,615105183 
ENSP00000351280_1 0,904943663 7,480643794 7,062170589 
JK122602.1_1 0,429983315 7,374349802 7,431683718 
ENSP00000315602_1 -4,190035741 -7,25636939 -3,135050294 
ENSP00000379256_1 1,066449422 -3,866519973 -4,991823929 
ENSP00000423390_1 -3,644061741 -7,141678295 -3,575839244 
ENSP00000293725_1 -0,59664408 3,709411665 4,337462117 
ENSP00000269080_1 -0,630529359 7,134921762 8,254007216 
JK114322.1_1 0,737772279 7,134921762 6,883037048 
ENSP00000349494_1 0,91906066 6,99844435 6,564161444 
ENSP00000330523_1 -0,030228358 6,847694402 7,364967387 
ENSP00000361761_1 0,654376735 6,847694402 6,678465391 
JK123883.1_1 -0,030228358 6,847694402 7,364967387 
ENSP00000348602_1 -0,160442277 4,073276058 4,292539848 
ENSP00000360425_1 0,35839136 4,073276058 3,772471476 
JK118565.1_1 -0,030228358 4,073276058 4,162056544 
ENSP00000296575_1 0,177465509 -3,587959848 -3,79719036 
ENSP00000334128_1 0 -6,880685804 -7,36774617 
ENSP00000395461_1 0,126862899 3,469983625 3,373084953 
JK103161.1_1 2,191436022 4,857734403 2,666509416 
JK103279.1_1 2,005712511 4,703728106 2,698830058 
JK091645.1_1 2,522419672 5,164893736 2,644113977 
ENSP00000318057_1 2,666370904 4,829074794 2,163754616 
ENSP00000245919_1 2,644377091 3,547294088 0,90293293 
ENSP00000242480_1 2,497774299 4,027637687 1,53026096 
ENSP00000363804_1 2,13852069 4,964637117 2,828322135 
ENSP00000260356_1 1,637389662 3,127718939 1,490366263 
JK094840.1_1 0,787952781 3,176915914 2,389149842 
ENSP00000359629_1 -0,758979662 -3,104593117 -2,345689701 
ENSP00000356954_1 1,651244365 3,53765141 1,886920773 
ENSP00000360158_1 -1,6351237 -3,473423208 -1,83844798 
ENSP00000358596_1 2,148068796 4,223098911 2,07682371 
JK112968.1_1 2,437010443 3,979545319 1,543729093 
ENSP00000274181_1 1,958861267 4,818018522 2,863558394 
JK097840.1_1 1,994601817 3,125399663 1,131351315 
JK112739.1_1 2,086300548 3,718485228 1,633703074 
ENSP00000282701_1 0,239787954 3,183357261 2,944568674 
ENSP00000308330_1 -2,617279258 -4,344491643 -1,728365222 
ENSP00000445626_1 2,785401556 3,849636795 1,067108629 
    
feature IDs p134 vs p127 p194 vs p127 p194 vs p134 
ENSP00000301599_1 1,400253782 3,854582882 2,459201487 
ENSP00000245552_1 0,162332495 3,066110186 2,906235486 
ENSP00000299308_1 -0,99991823 -3,236232338 -2,237545903 
ENSP00000194155_1 1,421591194 3,406454525 1,988466113 
ENSP00000221166_1 1,400683588 3,559445737 2,163409721 
JK105828.1_1 2,055296271 4,223245572 2,177195073 
ENSP00000216286_1 -1,591194153 -4,47001472 -2,882729627 
ENSP00000261304_1 0,894584408 3,019916207 2,127969875 
ENSP00000283309_1 1,188917879 4,050187454 2,871369672 
ENSP00000264867_1 1,657010326 3,678611508 2,02762736 
ENSP00000262018_1 -1,523411571 -3,111566748 -1,589164078 
JK105906.1_1 2,257841797 3,226439068 0,97130293 
JK099313.1_1 2,934227147 4,210248022 1,284749427 
JK092041.1_1 2,706715584 3,389340536 0,685715776 
ENSP00000288976_1 1,571957739 3,329318142 1,762468944 
ENSP00000324173_1 2,934227147 3,383633474 0,452085535 
ENSP00000296591_1 0,97157576 3,254045941 2,287623044 
JK113163.1_1 2,713279445 5,89431977 3,237105083 
ENSP00000379154_1 1,768040252 4,364385249 2,61556698 
JK100497.1_1 2,656383512 4,811661249 2,181807346 
ENSP00000454748_1 0,857824952 3,046042725 2,19514581 
ENSP00000282030_1 0,493757109 3,138413787 2,653084662 
ENSP00000467931_1 0,703720151 3,396632031 2,704712035 
JK118831.1_1 -1,782357491 -3,328664066 -1,54924862 
JK109094.1_1 1,764284619 3,851431503 2,10492557 
ENSP00000340864_1 1,096613274 4,007340696 2,939804851 
ENSP00000413163_1 0,722842408 3,145956732 2,434498678 
ENSP00000464976_1 0,674219467 3,145956732 2,483196658 
ENSP00000328358_1 -1,57936677 -3,474291898 -1,90004956 
JK091546.1_1 1,536444446 3,02167894 1,493013297 
ENSP00000416561_1 2,734855496 4,805222523 2,119404684 
ENSP00000238018_1 1,624044678 3,914702731 2,317650187 
ENSP00000378067_1 2,058018201 4,599931457 2,594492354 
ENSP00000272520_1 -5,366540222 -7,362610433 -2,05327193 
ENSP00000360315_1 0,575762649 3,152409358 2,591064047 
JK115319.1_1 0,951401772 3,152409358 2,214673973 
ENSP00000366477_1 -5,14996425 -7,200163253 -2,108598444 
JK097110.1_1 1,682023687 6,99844435 5,797403198 
ENSP00000261187_1 2,153530231 4,224026005 2,119404684 
ENSP00000395323_1 2,858528168 4,224026005 1,406279482 
ENSP00000331581_1 1,066386385 3,048117213 1,999016787 
ENSP00000242729_1 1,531230971 6,847694402 5,797403198 
JK095711.1_1 1,531230971 6,847694402 5,797403198 
JK108564.1_1 1,747806943 6,847694402 5,579327767 
JK116885.1_1 2,312594577 6,847694402 5,00937381 
ENSP00000354723_1 -2,184317246 -3,481718804 -1,304224693 
ENSP00000398131_1 -5,14996425 -6,807329438 -1,714877485 
 
